There were no differences in the percentages of Ki-67+ cells between control and CTHkd cells in the core or invasive fractions of the devices (Supplemental Figure 7A), confirming that invasive GBM cells with or without CTHkd did not exhibit proliferative differences. The gene discussed is MKI67; the disease is glioblastoma.